*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
Summary Sentence: BME Seminar Speaker - David Cormode, Ph.D.*
Full Summary: No summary paragraph submitted.
David Cormode, PhD*
David Cormode, PhD*
Assistant Professor of Radiology
Assistant Professor of Cardiology & Bioengineering
University of Pennsylvania
ABSTRACT
X-ray based imaging has been used in medicine for the past 120 years. Despite the age of this technology, we are in an era of rapid innovation in x-ray imaging methods. In particular, multi-energy x-ray imaging (such as dual energy mammography) is becoming widely available to patients, and is providing benefits such as more accurate cancer detection. These new imaging technologies require novel contrast agents that are specifically aligned to them, to allow high contrast generation. The development of such novel contrast agents will be described. For example, silver-based nanoparticles that provide improved contrast in dual energy mammography and are highly biocompatible will be discussed. Specific and multiplexed detection of contrast agents such as gold nanoparticles with spectral photon-counting computed tomography will be presented. These agents are designed for clinical translation and so their biodegradation and excretion will be discussed. Applications of these agents/systems for tumor detection, vascular imaging and cell tracking will be described.
Host: John Oshinski, Ph.D.
